2019-07-15T13:22:41-05:00 2018-09-28 910189318 MOSS ADAMS LLP 6565 AMERICAS PARKWAY NE STE 600 ALBUQUERQUE NM 87110 990 2017-09-30 850110669 LOVELACE RESPIRATORY RESEARCH INSTITUTE LOVE 5053489389 2425 RIDGECREST DRIVE SE ALBUQUERQUE NM 87108 SHANNON TOMA CHIEF OPERATING OFFICER 5053489389 2019-07-15 1 PAMELA ALEXANDERSON P01218925 5058787200 2019-07-15 12.129.7.100 2019-07-15 10:25:15 MD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 A175BBA534FC65FC8862446EC7D9FB11914B18F0 2017 2019-02-21 02:37:17Z ROBERT W RUBIN 2425 RIDGECREST DRIVE SE ALBUQUERQUE NM 87108 26950548 0 X WWW.LRRI.ORG X 1965 NM THE LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, TREATMENT AND CURE OF RESPIRATORY DISEASE. LRRI IS COMMITTED TO CURING RESPIRATORY DISEASES THROUGH RESEARCH AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY HEALTH HAZARDS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE (LBERI) IS A WHOLLY OWNED SUBSIDIARY OF LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI). LRRI MANAGES ALL GOVERNMENT CONTRACTS FOR LBERI. LBERI OFFERS CAPABILITIES FOR RESEARCH, DEVELOPMENT, TESTING, AND EVALUATION (RDT&E) TO PROVIDE IMPROVED MEDICAL COUNTERMEASURES AGAINST CHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR (CBRN), EMERGING, AND ENVIRONMENTAL THREATS. LRRI IS BASED IN ALBUQUERQUE, NEW MEXICO. 16 15 58 15 0 0 65 52159 9493238 14518227 1211528 3083631 -164787 -133303 10540044 17520714 0 0 0 0 7521547 7049563 0 0 0 13038349 8939560 20559896 15989123 -10019852 1531591 61729283 62218262 32677278 31813677 29052005 30404585 X THE LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI) IS A PRIVATE, BIOMEDICAL RESEARCH ORGANIZATION DEDICATED TO IMPROVING PUBLIC HEALTH THROUGH RESEARCH ON THE PREVENTION, TREATMENT AND CURE OF RESPIRATORY DISEASE. LRRI IS COMMITTED TO CURING RESPIRATORY DISEASES THROUGH RESEARCH AIMED AT UNDERSTANDING THEIR CAUSES AND BIOLOGICAL MECHANISMS; ASSESSING AND ELIMINATING EXPOSURES TO RESPIRATORY HEALTH HAZARDS; AND DEVELOPING IMPROVED THERAPEUTICS, VACCINES, AND DIAGNOSTICS. LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE (LBERI) IS A WHOLLY OWNED SUBSIDIARY OF LOVELACE RESPIRATORY RESEARCH INSTITUTE (LRRI). LRRI MANAGES ALL GOVERNMENT CONTRACTS FOR LBERI. LBERI OFFERS CAPABILITIES FOR RESEARCH, DEVELOPMENT, TESTING, AND EVALUATION (RDT&E) TO PROVIDE IMPROVED MEDICAL COUNTERMEASURES AGAINST CHEMICAL, BIOLOGICAL, RADIOLOGICAL, NUCLEAR (CBRN), EMERGING, AND ENVIRONMENTAL THREATS. LRRI IS BASED IN ALBUQUERQUE, NEW MEXICO. 0 0 12143452 14365878 MEDICAL RESEARCH AND EDUCATIONAL ACTIVITY IN THE AREAS OF BASIC BIOMEDICAL RESEARCH, HEALTH AND POPULATION STUDIES, PRIMARILY IN RESPIRATORY DISEASES SUCH AS ASTHMA, COPD, ALLERGY AND TOXIC EFFECTS OF ENVIRONMENTAL FACTORS. 12143452 1 1 0 1 0 0 0 0 0 0 1 0 1 0 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 52 0 1 58 1 0 0 0 0 0 0 0 0 0 0 X 16 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 NM X X SHANNON TOMA 5053489389 2425 RIDGECREST DRIVE SE ALBUQUERQUE NM 87108 JACKIE LOVELACE JOHNSON CHAIRMAN OF THE BOARD 2.00 4.00 X X 0 0 0 ROBERT RUBIN PHD CEO, PRESIDENT, DIRECTOR 2.00 48.00 X X 0 698337 40270 JAMES SWENBERG DVMPHD THRU 048 DIR, CHAIR - RESEARCH PROGRAMS 2.00 X X 0 0 0 JANE DELGADO DIR, CHAIR - NOMINATING CO 2.00 X X 0 0 0 CHRIS SPENCER CPA DIR, CHAIR - BUDGET & FINA 2.00 2.00 X X 0 0 0 PAMELA SULLIVAN DIR, CHAIR - AUDIT & COMPE 2.00 X X 0 0 0 DAVID DURGIN THROUGH 0418 DIR, CHAIR - ALTERNATIVE 2.00 X X 0 0 0 GREGORY DOWNEY MD DIRECTOR 2.00 X 0 0 0 J GRANT BURCHAM DIRECTOR 2.00 X 0 0 0 JACK MCCARTHY MD DIRECTOR 2.00 X 0 0 0 JOE FULCHER THROUGH 1017 DIRECTOR 2.00 X 0 0 0 MAJOR GENERAL JOHN DOESBURG DIRECTOR 2.00 X 0 0 0 MELVIN TWIEST MD DIRECTOR 2.00 X 0 0 0 AUGUSTINE CHOI MD DIRECTOR 2.00 X 0 0 0 SARA EASTERSON-BOND DIRECTOR 2.00 2.00 X 0 0 0 TESS BURLESON DIRECTOR 2.00 2.00 X 0 0 0 RICHARD GILL PHD DIRECTOR 2.00 X 0 0 0 SANDRA CHAVEZ DIRECTOR 2.00 X 0 0 0 TERRY DUNLAY DIRECTOR 2.00 X 0 0 0 SHANNON TOMA TREASURER, COO, CFO 2.00 48.00 X 318403 0 40172 MARGARET DUNBAR THROUGH - 0817 GNRL CNSL & SR DIR OF BUS 40.00 X 133634 0 21030 MATTHEW REED THROUGH 0318 DIR PRECILIN DRUG DEV/SCIENTIST 40.00 X 208529 0 34111 CHESTER LEACH SCIENTIST EMERITUS 16.00 X 146278 0 12119 DAVID FLANDERS HUMAN RESOURCES VICE PRESI 40.00 X 177206 0 24201 ERICA SMITH SR. DIR. COM SALES & MARK 40.00 X 190244 0 20057 1174294 698337 191960 7 0 1 0 CLIFTONLARSONALLEN LLP 6501 AMERICAS PARKWAY NE SUITE 500 ALBUQUERQUE NM 87110 ACCOUNTING SERVICES 475710 MOSS ADAMS LLP 6565 AMERICAS PARKWAY NE SUITE 500 ALBUQUERQUE NM 87110 AUDIT, TAX RETURN PREPARATION 168721 2 52159 52159 BIOMEDICAL RESEARCH 541700 12533701 12533701 INTERCOMPANY REIMBURSE 900099 1984526 1984526 14518227 1485765 1485765 14348 14348 11027700 9339048 90786 1688652 -90786 1597866 1597866 LOSS ON JOINT VENTURE 900000 -152349 -152349 4698 4698 -147651 17520714 14365878 0 3102677 X 478808 478808 4433778 1838405 2595373 51924 3467 48457 1844660 911742 932918 240393 40951 199442 79172 79172 750580 41280 709300 5700 5700 50167 50167 2168026 1734048 433978 43961 3028 40933 375657 102248 273409 830602 263831 566771 179431 4331 175100 134532 76044 58488 68137 40787 27350 1066746 1066746 582253 456862 125391 698883 698883 RESEARCH SUPPLIES 2589022 2589022 SUPPLIES 76704 51881 24823 MINOR EQUIPMENT 23055 2650 20405 INTERCOMPANY REIMBURSEM -948047 3977875 -4925922 164979 5000 159979 15989123 12143452 3845671 0 184000 123461 1940940 2663284 30152 5766 16778 8846 580485 542519 712344 676378 17126163 12732428 4932584 4393735 48289718 48734699 3548815 3472556 1493467 1597018 61729283 62218262 1420948 1808100 394007 1260639 29368856 27147920 1493467 1597018 32677278 31813677 X 29052005 30404585 29052005 30404585 61729283 62218262 1531591 -179011 0 X 0 1 X 1 1 1 X 13513313 14045783 52 65 52159 27611372 13513313 14045783 52 65 52159 27611372 27611372 2187594 2873885 2099472 1248480 1500113 9909544 880 -339932 -188296 -147651 -674999 36845917 58582025 0.74940 0.80870 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2013 AMOUNT: $ 880. 2015 AMOUNT: $ 577. 2017 AMOUNT: $ 4,698. HIGH WAGE TAX CREDIT - OTHER INCOME REBATES - TECHNOLOGY TAX CREDIT - CORPORATE ALLOCATION - BAD DEBT RECOVERY - 2015 AMOUNT: $ 33,646. LOSS ON JOINT VENTURES - 2015 AMOUNT: $ -374,155. 2016 AMOUNT: $ -188,296. 2017 AMOUNT: $ -152,349. X 5700 194240 5700 194240 12143552 51594208 12149252 51788448 757463 1000000 189366 250000 0 0 0 0 1000000 1000000 1000000 1000000 4000000 6000000 145058 168937 191280 194240 699515 250000 250000 250000 250000 1000000 1500000 104544 106913 211457 13115736 9495874 3619862 3283775 2724731 559044 515195 511823 3372 4393735 INVESTMENT IN LSR -911216 C INVESTMENT IN MRN 4383772 C 3472556 DEFERRED COMP 457(B) AND 457(F) 1597018 1597018 X PART X, LINE 2: MRN IS A NONPROFIT CORPORATION AND QUALIFIES AS A TAX EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED AS AN OTHER THAN PRIVATE FOUNDATION. AS SUCH, THEIR NORMAL ACTIVITIES DO NOT RESULT IN ANY INCOME TAX LIABILITIES. AS OF SEPTEMBER 28, 2018 AND SEPTEMBER 29, 2017, THE COMPANY PERFORMED A REVIEW OF ITS MATERIAL TAX POSITIONS IN ACCORDANCE WITH RECOGNITION AND MEASUREMENT STANDARDS ESTABLISHED BY US GAAP. AS A RESULT OF THIS REVIEW, LRRI QUALIFIED AS A TAX EXEMPT ORGANIZATION UNDER 501(C)(3) OF THE IRC AND HAD NO UNREPORTED INCOME DERIVED FROM UNRELATED BUSINESS ACTIVITIES AND DID NOT IDENTIFY ANY ENTITY LEVEL TAX POSITIONS FOR LRRI THAT WOULD NOT MEET THE MORE-LIKELY-THAN-NOT THRESHOLD. THE COMPANY FILES TAX RETURNS AS PRESCRIBED BY THE TAX LAWS OF THE JURISDICTIONS IN WHICH IT OPERATES. IN THE NORMAL COURSE OF BUSINESS, THE COMPANY IS SUBJECT TO EXAMINATION BY FEDERAL, STATE, LOCAL AND FOREIGN JURISDICTIONS, WHERE APPLICABLE. AS OF SEPTEMBER 28, 2018 AND SEPTEMBER 29, 2017, THE TAX YEARS THAT REMAIN SUBJECT TO EXAMINATION BY THE MAJOR TAX JURISDICTIONS UNDER THE STATUTE OF LIMITATIONS ARE FROM THE YEAR ENDED SEPTEMBER 30, 2015 AND FORWARD. MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES RESEARCH 152349 0 0 0 0 0 0 152349 0 152349 1 0 1 0 0 0 PART 1, LINE 3: THE ORGANIZATION USES THE EQUITY METHOD OF ACCOUNTING TO ACCOUNT FOR EXPENDITURES. X 0 0 X X X 1 1 0 0 0 0 0 1 0 ROBERT RUBIN PHD CEO, PRESIDENT, DIRECTOR 0 640529 0 0 0 57808 0 26381 0 13889 0 738607 0 0 SHANNON TOMA TREASURER, COO, CFO 302403 0 16000 0 0 0 26381 0 13791 0 358575 0 0 0 MARGARET DUNBAR THROUGH - 0817 GNRL CNSL & SR DIR OF BUS 133634 0 0 0 0 0 11925 0 9105 0 154664 0 0 0 MATTHEW REED THROUGH 0318 DIR PRECILIN DRUG DEV/SCIENTIST 208529 0 0 0 0 0 20069 0 14042 0 242640 0 0 0 CHESTER LEACH SCIENTIST EMERITUS 52674 0 93604 0 0 0 0 0 12119 0 158397 0 0 0 DAVID FLANDERS HUMAN RESOURCES VICE PRESI 175146 0 2060 0 0 0 16982 0 7219 0 201407 0 0 0 ERICA SMITH SR. DIR. COM SALES & MARK 161364 0 28880 0 0 0 18270 0 1787 0 210301 0 0 0 PART I, LINE 1A TAX INDEMNIFICATION AND GROSS-UP PAYMENTS IS CHECKED FOR THE SERP CONTRIBUTION FOR ROBERT W. RUBIN. PART I, LINES 4A-B ROBERT RUBIN 457(F) PLAN - 2017 CONTRIBUTION IS $41,810 PART I, LINE 7 BONUSES ARE AWARDED ANNUALLY. MANAGEMENT IS PROVIDED AN AMOUNT, APPROVED BY THE BOARD, TO PAY IN ANNUAL BONUS. BONUS PAYMENTS ARE REVIEWED AND APPROVED BY THE EMPLOYEE'S DIRECT SUPERVISOR, HUMAN RESOURCES, CHRO AND CEO. CEO BONUS IS ESTABLISHED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS. SHANNON TOMA EVP, COO IN CONNECTION WITH RELOCATION AGREEMENT X 50000 8846 0 1 1 8846 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PRESENTED IN DRAFT FORM TO THE AUDIT AND COMPENSATION COMMITTEE AND TO THE FULL BOARD FOR REVIEW PRIOR TO SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A CODE OF CONDUCT THAT ADDRESSES CONFLICTS OF INTEREST. IT IS PRESENTED TO THE BOARD ANNUALLY. ADDITIONALLY, ALL EMPLOYEES, INCLUDING OFFICERS, ARE REQUIRED TO READ AND ACKNOWLEDGE THE CODE ANNUALLY. IN ADDITION, IF A CONFLICT ARISES, THE CONFLICTED INDIVIDUAL RECUSES HIMSELF FROM VOTING ON THE ISSUE. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S AUDIT AND COMPENSATION COMMITTEES RECEIVE COMPENSATORY RECOMMENDATION FROM HUMAN RESOURCES AND FROM MANAGEMENT AS TO: 1. PERCENT BASE SALARY INCREASE FOR THE ORGANIZATION AS A WHOLE WITH TARGETS AND THE DOLLAR AMOUNT OF IMPACT ARE PRESENTED TO AND APPROVED BY THE AUDIT AND COMPENSATION COMMITTEE. 2. TARGET AMOUNT OF BONUS COMPENSATION FOR THE ENTIRE ORGANIZATION AND THE DOLLAR IMPACT ARE PRESENTED AND APPROVED BY THE AUDIT AND COMPENSATION COMMITTEE. 3. CEO COMPENSATION (BASE, BONUS AND DEFERRED COMPENSATION) IS REVIEWED TO MARKET VALUE FOR SIMILAR POSITIONS IN THE INDUCTRY AND APPROVED BY THE AUDIT AND COMPENSATION COMMITTEE. THIS PROCESS IS DOCUMENTED AND WAS LAST COMPLETED IN OCTOBER 2018. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE PUBLIC DISCLOSURE COPY OF THE FORM 990 IS ALSO AVAILABLE VIA GUIDESTAR AND AT THE NEW MEXICO ATTORNEY GENERAL'S OFFICE'S CHARITABLE ORGANIZATION REGISTRATION SYSTEM (NM-COROS). FORM 990, PART IX, LINE 11G SUBCONTRACTORS: PROGRAM SERVICE EXPENSES 668,693. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 668,693. PROFESSIONAL SERVICES: PROGRAM SERVICE EXPENSES 1,065,355. MANAGEMENT AND GENERAL EXPENSES 433,978. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,499,333. LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE 2425 RIDGECREST DRIVE SE ALBUQUERQUE NM 87108 510154068 MEDICAL RESEARCH SEEKING THE CAUSES AND CURES FOR RESPIRATORY DISEASES NM 501(C)(3) 7 LOVELACE RESPIRATORY RESEARCH INSTITUTE 1 THE MIND RESEARCH NETWORK 1101 YALE BLVD NE ALBUQUERQUE NM 87106 850457562 MEDICAL RESEARCH SEEKING THE CAUSES AND CURES FOR BRAIN DISORDERS NM 501(C)(3) 7 LOVELACE RESPIRATORY RESEARCH INSTITUTE 1 LOVELACE SCIENTIFIC RESOURCES 2441 RIDGECREST DR SE ALBUQUERQUE NM 87108 850357767 SCIENTIFIC RESEARCH NM LOVELACE RESPIRATORY RESEARCH INSTITUTE C -278458 720186 1.00000 1 0 0 0 1 0 0 0 0 0 0 0 0 1 1 1 1 1 0 0 LOVELACE SCIENTIFIC RESOURCES Q 60712 LOVELACE BIOMEDICAL AND ENVIRONMENTAL INSTITUTE Q 2573205 THE MIND RESEARCH NETWORK Q 73465 LOVELACE BIOMEDICAL AND ENVIRONMENTAL INST O 1078183 THE MIND RESEARCH NETWORK O 120855 THE MIND RESEARCH NETWORK P 625623 THE MIND RESEARCH NETWORK D 542519 LOVELACE BIOMEDICAL AND ENVIRONMENTAL INSTITUTE 2425 RIDGECREST DR SE ALBUQUERQUE NM 87108 540154068 X 0 188640 188640 28400359 28588999 1000000 250000 0 0 0 LOVELACE RESPIRATORY RESEARCH INSTITUTE 2425 RIDGECREST DR SE ALBUQUERQUE NM 87108 850110669 X 0 5700 5700 12143552 12149252 757463 189366 0 0 0 THE MIND RESEARCH NETWORK 1101 YALE BLVD NE ALBUQUERQUE NM 87106 850457562 0 0 0 11050297 11050297 702515 175629 0 0 0